HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alessandro Prinetti Selected Research

Type A Niemann-Pick Disease

7/2022Massive Accumulation of Sphingomyelin Affects the Lysosomal and Mitochondria Compartments and Promotes Apoptosis in Niemann-Pick Disease Type A.
9/2011Secondary alterations of sphingolipid metabolism in lysosomal storage diseases.
3/2011Brain pathology in Niemann Pick disease type A: insights from the acid sphingomyelinase knockout mice.
4/2009Alterations of myelin-specific proteins and sphingolipids characterize the brains of acid sphingomyelinase-deficient mice, an animal model of Niemann-Pick disease type A.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Alessandro Prinetti Research Topics

Disease

13Neoplasms (Cancer)
06/2021 - 06/2005
9Neurodegenerative Diseases (Neurodegenerative Disease)
01/2020 - 04/2009
8Carcinoma (Carcinomatosis)
11/2011 - 02/2003
5Brain Diseases (Brain Disorder)
07/2022 - 06/2010
4Type A Niemann-Pick Disease
07/2022 - 04/2009
4Alzheimer Disease (Alzheimer's Disease)
01/2020 - 06/2010
4Neuroblastoma
12/2012 - 01/2005
3Niemann-Pick Diseases (Niemann Pick Disease)
07/2022 - 04/2009
3Sphingolipidoses (Sphingolipidosis)
01/2021 - 08/2014
3Parkinson Disease (Parkinson's Disease)
01/2018 - 06/2010
3Ovarian Neoplasms (Ovarian Cancer)
11/2011 - 04/2006
2Multiple Sclerosis
01/2020 - 02/2016
2Lysosomal Storage Diseases (Lysosomal Storage Disease)
01/2019 - 09/2011
2Neoplasm Metastasis (Metastasis)
03/2008 - 06/2005
2Melanoma (Melanoma, Malignant)
08/2007 - 06/2005
1Demyelinating Diseases (Demyelinating Disease)
01/2021
1Obesity
01/2020
1Relapsing-Remitting Multiple Sclerosis
01/2019
1Prostatic Neoplasms (Prostate Cancer)
01/2018
1Motor Neuron Disease (Primary Lateral Sclerosis)
01/2017
1Guillain-Barre Syndrome
01/2017
1Peripheral Nervous System Diseases (PNS Diseases)
01/2017
1Pain (Aches)
08/2016
1Cholera
04/2016
1GM2 Gangliosidoses (GM2 Gangliosidosis)
08/2014
1Inborn Genetic Diseases (Disease, Hereditary)
08/2014
1Nervous System Diseases (Neurological Disorders)
08/2014
1Sandhoff Disease (Sandhoff's Disease)
08/2014
1Gaucher Disease (Gaucher's Disease)
11/2012
1Huntington Disease (Huntington's Disease)
06/2010
1Inflammation (Inflammations)
01/2010
1Osteopetrosis
08/2009
1Atrophy
04/2009
1Autoimmune Diseases (Autoimmune Disease)
09/2008

Drug/Important Bio-Agent (IBA)

16SphingolipidsIBA
07/2022 - 02/2003
8LipidsIBA
01/2020 - 08/2009
6CeramidesIBA
06/2021 - 04/2006
6Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA
12/2012 - 04/2006
5SphingomyelinsIBA
07/2022 - 04/2006
5EnzymesIBA
01/2021 - 02/2007
5Proteins (Proteins, Gene)FDA Link
01/2018 - 04/2009
5AcidsIBA
09/2011 - 04/2006
4Caveolin 1IBA
11/2011 - 08/2007
4FenretinideIBA
07/2010 - 02/2003
4RetinoidsIBA
07/2010 - 03/2006
3dihydroceramideIBA
01/2021 - 06/2010
3SphingosineIBA
01/2021 - 01/2005
3G(M3) GangliosideIBA
01/2020 - 08/2007
3Neuraminidase (Sialidase)IBA
05/2015 - 02/2007
3GangliosidesIBA
11/2011 - 04/2006
2sphingosine 1-phosphate (sphingosine-1-phosphate)IBA
06/2021 - 01/2019
2G(M2) Ganglioside (Ganglioside GM2)IBA
08/2014 - 07/2010
2Liver X ReceptorsIBA
08/2013 - 01/2010
2GlycosphingolipidsIBA
11/2011 - 01/2011
2haematoside synthetaseIBA
11/2011 - 01/2010
2IntegrinsIBA
11/2011 - 03/2008
2neodymium pyrocatechin disulfonate (NPD)IBA
03/2011 - 04/2009
24-oxofenretinideIBA
07/2010 - 03/2006
2CholesterolIBA
01/2010 - 06/2005
1Chimeric Antigen ReceptorsIBA
06/2021
1Monoclonal AntibodiesIBA
06/2021
1InterleukinsIBA
06/2021
1VaccinesIBA
06/2021
1AntigensIBA
06/2021
1Galactosylceramides (Galactocerebrosides)IBA
01/2021
1Glucosylceramides (Glucocerebrosides)IBA
01/2021
1safingol (sphinganine)IBA
01/2021
1HydrolasesIBA
01/2019
1Fingolimod Hydrochloride (FTY720)FDA Link
01/2019
1Macromolecular SubstancesIBA
01/2018
1neuromelaninIBA
01/2018
1abirateroneIBA
01/2018
1AntibodiesIBA
01/2017
1OligosaccharidesIBA
01/2017
1Polysaccharides (Glycans)IBA
01/2017
1Cannabinoid Receptors (Cannabinoid Receptor)IBA
08/2016
1Bacterial ToxinsIBA
04/2016
1Sulfoglycosphingolipids (Sulfatides)IBA
02/2016
1Hexosaminidases (Hexosaminidase)IBA
08/2014
1Pyrimethamine (Daraprim)FDA Link
08/2014
1OxysterolsIBA
08/2013
1GlucosidasesIBA
12/2012
1GalactosidasesIBA
12/2012
1Glycoside Hydrolases (Endoglycosidases)IBA
11/2012
1Glucosylceramidase (Glucocerebrosidase)IBA
11/2012
1retinamideIBA
11/2011
1SialyltransferasesIBA
11/2011
1Fatty Acids (Saturated Fatty Acids)IBA
07/2010
1CDw17 antigen (lactosylceramide)IBA
07/2010
1sphingosine kinaseIBA
06/2010
1alpha-SynucleinIBA
06/2010
1Protein Isoforms (Isoforms)IBA
06/2010
1Amyloid beta-PeptidesIBA
06/2010
1PrionsIBA
06/2010
1SulfotransferasesIBA
01/2010
1LigandsIBA
01/2010
1CC ChemokinesIBA
01/2010

Therapy/Procedure

4Therapeutics
01/2021 - 08/2013
2Radiotherapy
01/2018 - 10/2014
1Immunotherapy
06/2021